Sophia Koutsogiannaki, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anesthetics, Inhalation | 9 | 2022 | 571 | 2.450 |
Why?
|
Isoflurane | 11 | 2022 | 384 | 2.420 |
Why?
|
Mytilus | 5 | 2014 | 7 | 1.710 |
Why?
|
Sepsis | 6 | 2024 | 2592 | 1.270 |
Why?
|
Neutrophils | 9 | 2024 | 3735 | 1.220 |
Why?
|
Toll-Like Receptor 4 | 3 | 2024 | 579 | 1.040 |
Why?
|
Water Pollutants, Chemical | 4 | 2014 | 344 | 0.980 |
Why?
|
Cadmium | 4 | 2014 | 215 | 0.930 |
Why?
|
Propofol | 6 | 2022 | 582 | 0.920 |
Why?
|
Phagocytosis | 7 | 2023 | 1530 | 0.860 |
Why?
|
Dexmedetomidine | 2 | 2024 | 314 | 0.850 |
Why?
|
Estradiol | 3 | 2014 | 1940 | 0.790 |
Why?
|
Macrophage-1 Antigen | 3 | 2022 | 286 | 0.770 |
Why?
|
Toll-Like Receptor 5 | 1 | 2021 | 41 | 0.760 |
Why?
|
Flagellin | 2 | 2021 | 124 | 0.750 |
Why?
|
Receptors, Pattern Recognition | 1 | 2021 | 83 | 0.720 |
Why?
|
Pseudomonas Infections | 2 | 2024 | 618 | 0.710 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 2 | 2022 | 375 | 0.710 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2019 | 27 | 0.690 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 233 | 0.660 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 359 | 0.620 |
Why?
|
Acute Lung Injury | 1 | 2022 | 369 | 0.610 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2021 | 491 | 0.610 |
Why?
|
Bacterial Load | 1 | 2018 | 151 | 0.610 |
Why?
|
Anesthetics | 2 | 2021 | 515 | 0.610 |
Why?
|
Mycoses | 1 | 2021 | 383 | 0.610 |
Why?
|
Lung Injury | 1 | 2022 | 426 | 0.600 |
Why?
|
Peritoneal Cavity | 1 | 2017 | 141 | 0.560 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1822 | 0.540 |
Why?
|
Microglia | 1 | 2024 | 1335 | 0.520 |
Why?
|
Cystic Fibrosis | 2 | 2024 | 1264 | 0.510 |
Why?
|
Hemocytes | 2 | 2013 | 44 | 0.490 |
Why?
|
Virus Diseases | 1 | 2021 | 721 | 0.490 |
Why?
|
Complement Inactivating Agents | 3 | 2019 | 52 | 0.460 |
Why?
|
Perioperative Care | 1 | 2021 | 1025 | 0.440 |
Why?
|
Rats, Sprague-Dawley | 1 | 2024 | 8167 | 0.440 |
Why?
|
Bacterial Infections | 1 | 2021 | 1401 | 0.430 |
Why?
|
Peptides, Cyclic | 3 | 2019 | 393 | 0.390 |
Why?
|
Complement C3b | 3 | 2022 | 99 | 0.390 |
Why?
|
Integrin alpha2 | 1 | 2011 | 39 | 0.380 |
Why?
|
Reactive Oxygen Species | 5 | 2023 | 2106 | 0.370 |
Why?
|
Anesthesia | 1 | 2021 | 1554 | 0.350 |
Why?
|
Heart Defects, Congenital | 3 | 2021 | 4730 | 0.330 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1513 | 0.330 |
Why?
|
Neutrophil Infiltration | 3 | 2022 | 392 | 0.320 |
Why?
|
Epithelial Cells | 1 | 2021 | 3672 | 0.320 |
Why?
|
Hemorrhage | 1 | 2021 | 3595 | 0.320 |
Why?
|
Environmental Monitoring | 2 | 2014 | 1428 | 0.320 |
Why?
|
Animals | 27 | 2024 | 167149 | 0.320 |
Why?
|
Complement C3 | 3 | 2018 | 448 | 0.290 |
Why?
|
Cadmium Poisoning | 1 | 2006 | 11 | 0.280 |
Why?
|
Mice | 14 | 2024 | 80745 | 0.270 |
Why?
|
Lung | 2 | 2022 | 9918 | 0.260 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 3632 | 0.260 |
Why?
|
Binding Sites | 5 | 2020 | 6046 | 0.250 |
Why?
|
Medetomidine | 1 | 2024 | 4 | 0.250 |
Why?
|
Anesthetics, Intravenous | 2 | 2018 | 387 | 0.240 |
Why?
|
HEK293 Cells | 3 | 2024 | 4233 | 0.240 |
Why?
|
Protein Binding | 5 | 2024 | 9310 | 0.230 |
Why?
|
Apoptosis | 1 | 2019 | 9452 | 0.220 |
Why?
|
Oxidative Stress | 2 | 2013 | 3062 | 0.220 |
Why?
|
Leukotriene B4 | 2 | 2022 | 281 | 0.220 |
Why?
|
Zinc | 2 | 2009 | 687 | 0.210 |
Why?
|
Greece | 2 | 2014 | 340 | 0.210 |
Why?
|
Complement Factor H | 1 | 2022 | 109 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.200 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1445 | 0.200 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2022 | 93 | 0.200 |
Why?
|
Inflammation | 1 | 2021 | 10717 | 0.190 |
Why?
|
Toll-Like Receptor 7 | 1 | 2022 | 178 | 0.190 |
Why?
|
Xenon | 1 | 2021 | 108 | 0.190 |
Why?
|
Signal Transduction | 4 | 2021 | 23278 | 0.180 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18027 | 0.180 |
Why?
|
Interferon-beta | 1 | 2022 | 343 | 0.180 |
Why?
|
Immunity, Innate | 2 | 2023 | 3036 | 0.180 |
Why?
|
Eicosanoids | 1 | 2022 | 278 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8565 | 0.170 |
Why?
|
Horses | 1 | 2020 | 297 | 0.170 |
Why?
|
Pseudomonas aeruginosa | 3 | 2024 | 1266 | 0.160 |
Why?
|
Chemotaxis | 1 | 2022 | 594 | 0.160 |
Why?
|
Methyl Ethers | 2 | 2017 | 195 | 0.160 |
Why?
|
Ketamine | 1 | 2024 | 508 | 0.160 |
Why?
|
Protein Multimerization | 2 | 2020 | 976 | 0.160 |
Why?
|
Hemostasis | 1 | 2021 | 466 | 0.160 |
Why?
|
Cyclic AMP | 2 | 2013 | 1459 | 0.150 |
Why?
|
Interferon-alpha | 1 | 2022 | 915 | 0.150 |
Why?
|
Interleukin-8 | 1 | 2021 | 701 | 0.150 |
Why?
|
Neuroprotective Agents | 1 | 2024 | 956 | 0.150 |
Why?
|
Deuterium Exchange Measurement | 1 | 2017 | 31 | 0.150 |
Why?
|
Oxidants | 2 | 2009 | 169 | 0.140 |
Why?
|
Imidazolidines | 1 | 2016 | 38 | 0.140 |
Why?
|
Shock, Hemorrhagic | 1 | 2019 | 224 | 0.140 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2017 | 93 | 0.140 |
Why?
|
Protein Carbonylation | 2 | 2013 | 27 | 0.140 |
Why?
|
Collateral Circulation | 1 | 2017 | 282 | 0.140 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2017 | 126 | 0.140 |
Why?
|
Wound Infection | 1 | 2018 | 242 | 0.130 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 692 | 0.130 |
Why?
|
Humans | 26 | 2024 | 755533 | 0.130 |
Why?
|
Cardiopulmonary Bypass | 1 | 2021 | 1091 | 0.130 |
Why?
|
Child | 8 | 2024 | 79427 | 0.130 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 262 | 0.130 |
Why?
|
Macaca fascicularis | 4 | 2019 | 905 | 0.130 |
Why?
|
Leukocytes | 1 | 2023 | 2030 | 0.120 |
Why?
|
Respiration Disorders | 1 | 2018 | 369 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2021 | 1154 | 0.120 |
Why?
|
Macrophages | 2 | 2020 | 5705 | 0.120 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10057 | 0.120 |
Why?
|
Mice, Knockout | 2 | 2022 | 14330 | 0.120 |
Why?
|
Pulmonary Circulation | 1 | 2017 | 742 | 0.120 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2015 | 94 | 0.120 |
Why?
|
Complement Activation | 1 | 2016 | 444 | 0.120 |
Why?
|
Antioxidants | 3 | 2014 | 1649 | 0.120 |
Why?
|
Hypnotics and Sedatives | 1 | 2022 | 1155 | 0.120 |
Why?
|
Mice, Inbred C57BL | 4 | 2022 | 21790 | 0.120 |
Why?
|
RNA, Viral | 1 | 2022 | 2828 | 0.110 |
Why?
|
Cytokines | 2 | 2020 | 7263 | 0.110 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2018 | 452 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1774 | 0.110 |
Why?
|
Staphylococcus aureus | 2 | 2018 | 1456 | 0.110 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1547 | 0.110 |
Why?
|
Lipid Peroxidation | 1 | 2013 | 255 | 0.110 |
Why?
|
Infant | 4 | 2023 | 35867 | 0.100 |
Why?
|
Escherichia coli | 3 | 2023 | 4211 | 0.100 |
Why?
|
NF-kappa B | 1 | 2021 | 2481 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1874 | 0.100 |
Why?
|
Pneumonia | 1 | 2024 | 2126 | 0.100 |
Why?
|
Enzymes | 1 | 2013 | 262 | 0.100 |
Why?
|
Child, Preschool | 5 | 2023 | 41893 | 0.100 |
Why?
|
Infant, Newborn | 2 | 2023 | 26039 | 0.100 |
Why?
|
T-Lymphocyte Subsets | 1 | 2020 | 1790 | 0.100 |
Why?
|
Monocytes | 1 | 2020 | 2562 | 0.090 |
Why?
|
Fontan Procedure | 1 | 2017 | 793 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2022 | 2719 | 0.090 |
Why?
|
Pyridones | 1 | 2016 | 782 | 0.090 |
Why?
|
Anesthesiology | 1 | 2021 | 1088 | 0.090 |
Why?
|
Periodontitis | 1 | 2016 | 562 | 0.090 |
Why?
|
Oxidation-Reduction | 2 | 2014 | 2213 | 0.090 |
Why?
|
Collagen Type IV | 1 | 2011 | 128 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2606 | 0.090 |
Why?
|
Hemolymph | 1 | 2009 | 27 | 0.080 |
Why?
|
Laminin | 1 | 2011 | 404 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 1173 | 0.080 |
Why?
|
Rats | 1 | 2024 | 23588 | 0.080 |
Why?
|
Estrogens | 1 | 2014 | 1520 | 0.070 |
Why?
|
Killer Cells, Natural | 1 | 2016 | 2178 | 0.070 |
Why?
|
Wound Healing | 1 | 2018 | 2782 | 0.070 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16793 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2011 | 827 | 0.070 |
Why?
|
Antimycin A | 1 | 2006 | 31 | 0.070 |
Why?
|
Gills | 1 | 2006 | 21 | 0.070 |
Why?
|
Rotenone | 1 | 2006 | 45 | 0.070 |
Why?
|
Amiloride | 1 | 2006 | 116 | 0.070 |
Why?
|
Receptors, Adrenergic | 1 | 2006 | 155 | 0.070 |
Why?
|
Oxygen | 1 | 2017 | 4175 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2018 | 15576 | 0.070 |
Why?
|
Bacteria | 1 | 2017 | 2175 | 0.070 |
Why?
|
Biofilms | 2 | 2022 | 617 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3554 | 0.060 |
Why?
|
Naphthalenes | 1 | 2006 | 191 | 0.060 |
Why?
|
Pyruvic Acid | 1 | 2006 | 195 | 0.060 |
Why?
|
Retrospective Studies | 4 | 2021 | 79686 | 0.060 |
Why?
|
Acetylcysteine | 1 | 2006 | 264 | 0.060 |
Why?
|
Male | 11 | 2022 | 356577 | 0.060 |
Why?
|
Cell Adhesion | 1 | 2011 | 3094 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10180 | 0.060 |
Why?
|
DNA Damage | 1 | 2013 | 2413 | 0.060 |
Why?
|
Xylazine | 1 | 2023 | 12 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15746 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18366 | 0.050 |
Why?
|
PPAR gamma | 1 | 2006 | 485 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13427 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2006 | 465 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2016 | 3073 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2015 | 5087 | 0.050 |
Why?
|
Cell Aggregation | 1 | 2022 | 239 | 0.050 |
Why?
|
Gram-Positive Bacteria | 1 | 2023 | 179 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11898 | 0.050 |
Why?
|
Gram-Negative Bacteria | 1 | 2023 | 273 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2006 | 2515 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 41119 | 0.050 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2024 | 444 | 0.050 |
Why?
|
Urea | 1 | 2022 | 442 | 0.040 |
Why?
|
Lymphocyte Antigen 96 | 1 | 2019 | 20 | 0.040 |
Why?
|
Risk Factors | 3 | 2021 | 73860 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 39961 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10683 | 0.040 |
Why?
|
Peptides | 2 | 2022 | 4314 | 0.040 |
Why?
|
Glutamic Acid | 1 | 2022 | 1162 | 0.040 |
Why?
|
Solid Phase Extraction | 1 | 2016 | 30 | 0.040 |
Why?
|
Sheep | 1 | 2019 | 1437 | 0.030 |
Why?
|
Arachidonic Acids | 1 | 2017 | 295 | 0.030 |
Why?
|
Surface Plasmon Resonance | 1 | 2017 | 265 | 0.030 |
Why?
|
Cell Survival | 1 | 2006 | 5783 | 0.030 |
Why?
|
Female | 6 | 2021 | 387920 | 0.030 |
Why?
|
Gingival Crevicular Fluid | 1 | 2016 | 93 | 0.030 |
Why?
|
Periodontal Index | 1 | 2016 | 150 | 0.030 |
Why?
|
Periodontal Attachment Loss | 1 | 2016 | 144 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2017 | 428 | 0.030 |
Why?
|
Periodontal Pocket | 1 | 2016 | 166 | 0.030 |
Why?
|
Enterococcus faecalis | 1 | 2017 | 247 | 0.030 |
Why?
|
Opsonin Proteins | 1 | 2015 | 146 | 0.030 |
Why?
|
Granzymes | 1 | 2016 | 274 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2018 | 2286 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2022 | 1686 | 0.030 |
Why?
|
Hemolysis | 1 | 2015 | 423 | 0.030 |
Why?
|
Models, Immunological | 1 | 2015 | 505 | 0.030 |
Why?
|
Bone Marrow | 1 | 2023 | 2902 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 18939 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15651 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2018 | 2316 | 0.030 |
Why?
|
Young Adult | 1 | 2018 | 58025 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9484 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4280 | 0.020 |
Why?
|
Adolescent | 1 | 2018 | 87236 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2017 | 1059 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3785 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2181 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2006 | 5609 | 0.020 |
Why?
|
Acetone | 1 | 2009 | 44 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5042 | 0.020 |
Why?
|
Malondialdehyde | 1 | 2009 | 104 | 0.020 |
Why?
|
Adult | 2 | 2024 | 217986 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2016 | 2370 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9372 | 0.020 |
Why?
|
Aged | 1 | 2020 | 167376 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5863 | 0.020 |
Why?
|
Swine | 1 | 2016 | 5899 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2405 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2447 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9254 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15647 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7342 | 0.020 |
Why?
|
Myocardium | 1 | 2016 | 4673 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4228 | 0.010 |
Why?
|
Heart | 1 | 2016 | 4387 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7946 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14636 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10392 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21239 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19987 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36042 | 0.010 |
Why?
|